Gabapentine Impurity 65 | CAS 3037693-16-3 - Request Quote
Gabapentine Impurity 65
| SZ CAT No: | SZ-G001090 |
| CAS No | 3037693-16-3 |
| Mol.F. | C9H15NO3 |
| Mol.Wt. | 185.2 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Gabapentine Impurity 65 is chemically 2-(1-Carbamoylcyclohexyl)acetic acid. Gabapentine Impurity 65 is supplied with detailed characterization data compliant with regulatory guideline. Gabapentine Impurity 65 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Gabapentin.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 3037693-16-3
Purchase 3037693-16-3
Order 3037693-16-3
Enquire 3037693-16-3
price of 3037693-16-3
3037693-16-3 Supplier
3037693-16-3 Manufacturer
3037693-16-3 Exporter
buy high quality Gabapentine Impurity 65
Purchase Gabapentine Impurity 65
Gabapentine Impurity 65 suppliers
Gabapentine Impurity 65 manufacturers
Gabapentine Impurity 65 price
Order Gabapentine Impurity 65
Enquire Gabapentine Impurity 65
Gabapentine Impurity 65 cost
Gabapentine Impurity 65 Supplier
Gabapentine Impurity 65 Distributor
Gabapentine Impurity 65 for Method Validation
Gabapentin Reference Standard
Gabapentine Impurity 65 for ANDA Filing
Gabapentine Impurity 65 for Forced Degradation Studies
Gabapentine Impurity 65 Identification Standards
Gabapentine Impurity 65 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.